Budesonide/Formoterol Therapy Increases FEV1 in Stem Cell Transplant–associated Bronchiolitis Obliterans Syndrome

Synopsis: In patients with mild to severe bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation, the administration of inhaled budesonide\formoterol led to a significant improvement in FEV1. Source: Bergeron A, Chevret S, Chagnon K, Godet C, Bergot E, Peffault de Latour R, Dominique S, de Revel T, Juvin K, Maillard N, et al. Budesonide/formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation. Am J Respir Crit Care Med. 2015;191(11):1242–1249.
Source: Clinical Pulmonary Medicine - Category: Respiratory Medicine Tags: Pulmonary Trends Source Type: research